<DOC>
	<DOCNO>NCT01796873</DOCNO>
	<brief_summary>Plavix ( clopidogrel ) drug approve FDA ( Food Drug Administration ) reduce risk another heart attack prevent platelet ( blood cell important form blood clot ) stick together form another clot . Platelet activity measure machine call VerifyNow . The purpose study see whether Hispanic woman White non-Hispanic woman platelet response commonly use drug , Plavix ( clopidogrel ) . Recent study show platelet may active Hispanics , make difficult prevent clot form , even use Plavix . In addition , study show woman may also active platelet men . There study Hispanic woman effect Plavix platelet activity .</brief_summary>
	<brief_title>Clopidogrel Resistance Platelet Reactivity Women Undergoing Percutaneous Coronary Intervention</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>All female age 45 great , present University Arizona Medical Center South Campus University Campus Cardiology service history ACS Hispanics define via selfreporting parent Latino descent Currently take clopidogrel Taking follow antiplatelet drug : Prasugrel ( Effient ) Ticagrelor ( Brilinta ) Ticlopidine ( Ticlid )</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Female</keyword>
	<keyword>Hispanic</keyword>
	<keyword>Percutaneous Coronary Intervention</keyword>
</DOC>